Sort
23,748 grants matching “melanoma”
Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy
$113,868Noha Abdelwahab Hassan Ali Hassan · University Of Tx Md Anderson Can Ctr · K01 · FY2024 · AI
Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy
$113,868Noha Abdelwahab Hassan Ali Hassan · University Of Tx Md Anderson Can Ctr · K01 · FY2023 · AI
Obesity and mortality after breast cancer diagnosis by race/ethnicity in the WHI Clinical Trial and Observational Cohorts
$113,842Garnet L. Anderson · Fred Hutchinson Cancer Research Center · UM1 · FY2015 · CA
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
$113,822Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors
$113,788Sun Yang · Chapman University · K08 · FY2016 · CA
Biologic therapy of Melanoma and Renal Cell Cancer
$113,719Beth Israel Deaconess Medical Center · K24 · FY2003 · CA
University of New Mexico Cancer Center Support Grant
$113,625Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2019 · CA
University of New Mexico Cancer Center Support Grant
$113,625Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2016 · CA
University of New Mexico Cancer Center Support Grant
$113,625Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2017 · CA
University of New Mexico Cancer Center Support Grant
$113,625Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2018 · CA
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis
$113,616Florian Karreth · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
HYALURONAN AND TUMOR PROGRESSION
$113,598Georgetown University · R29 · FY2000 · CA
UCLA/JCCC--SOUTHWEST ONCOLOGY GROUP
$113,582University Of California Los Angeles · U10 · FY2001 · CA
Altering Post Vaccination T Cell Contraction
$113,565Medical University Of South Carolina · R01 · FY2005 · CA
CALCINEURIN-NFAT AXIS IS A POTENTIAL THERAPEUTIC TARGET FOR UVEAL MELANOMA METASTASIS. NEW AWARD
$113,565University Of Utah · · FY2020 · Defense Health Agency
Data Bank and Bio Repository Shared Resource
$113,486Donald L Trump · Roswell Park Cancer Institute Corp · P30 · FY2015 · CA
Data Bank and Bio Repository Shared Resource
$113,480Donald L Trump · Roswell Park Cancer Institute Corp · P30 · FY2017 · CA
Data Bank and Bio Repository Shared Resource
$113,480Donald L Trump · Roswell Park Cancer Institute Corp · P30 · FY2016 · CA
A Patient Oriented Research Program for Surgical Oncologists
$113,392James S Goydos · Rbhs -Cancer Institute Of New Jersey · K24 · FY2014 · CA
Patterns of Care (POC) Quality of Care Dx Yr 2011
$113,271Sally Glasser · Cancer Prevention Instit Of California · N01 · FY2012 · CA
University of New Mexico Cancer Center Support Grant
$113,250Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2015 · CA
Understanding and enhancing mechanisms of priming in cancer immunotherapy
$113,250Grace Elizabeth Pluhar · University Of Minnesota · R21 · FY2011 · NS
Prevention of UVB-induced skin cancer using sulforaphane: roles of AP-1 and Nrf2.
$113,170Sally E Dickinson · University Of Arizona · K07 · FY2009 · CA
The Development of Novel Mechanistically-based APE/Ref-1 Redox Inhibitors
$113,074Sun Yang · Chapman University · K08 · FY2017 · CA
Molecular Determinants of Brain metastatic Melanoma
$113,003Louisiana State Univ A&M Col Baton Rouge · R01 · FY2004 · CA